search
Back to results

Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery

Primary Purpose

Oropharyngeal Neoplasms

Status
Unknown status
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Peri-Neuronal Catheter
Sponsored by
Gustave Roussy, Cancer Campus, Grand Paris
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Oropharyngeal Neoplasms focused on measuring Oro-Pharyngeal Carcinoma Surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Adult patients scheduled for oro-pharyngeal carcinoma surgery with reconstruction by fibula free flap Exclusion Criteria: Allergy to propofol or local anesthetic (ropivacaine) Severe renal or cardiac failure

Sites / Locations

  • Institut Gustave RoussyRecruiting

Outcomes

Primary Outcome Measures

Assess the influence of locoregional anesthesia on postoperative morphine consumption

Secondary Outcome Measures

Visual analog pain scale on the free flap donor site

Full Information

First Posted
September 13, 2005
Last Updated
August 27, 2007
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT00181038
Brief Title
Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery
Official Title
Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery: Comparing Continuous Infusion of Local Anesthetic With Systemic Multimodal Analgesia
Study Type
Interventional

2. Study Status

Record Verification Date
September 2006
Overall Recruitment Status
Unknown status
Study Start Date
June 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Gustave Roussy, Cancer Campus, Grand Paris

4. Oversight

5. Study Description

Brief Summary
This trial examines the analgesia of the fibula free flap donor site by peri-neuronal catheter in oro-pharyngeal carcinoma surgery by comparing continuous infusion of a local anesthetic with systemic multimodal analgesia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oropharyngeal Neoplasms
Keywords
Oro-Pharyngeal Carcinoma Surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Peri-Neuronal Catheter
Primary Outcome Measure Information:
Title
Assess the influence of locoregional anesthesia on postoperative morphine consumption
Secondary Outcome Measure Information:
Title
Visual analog pain scale on the free flap donor site

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients scheduled for oro-pharyngeal carcinoma surgery with reconstruction by fibula free flap Exclusion Criteria: Allergy to propofol or local anesthetic (ropivacaine) Severe renal or cardiac failure
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Frédéric Plantevin, MD
Phone
33 1 42 11 44 37
Email
plantevin@igr.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frédéric Plantevin, MD
Organizational Affiliation
Gustave Roussy, Cancer Campus, Grand Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut Gustave Roussy
City
Villejuif
ZIP/Postal Code
94800
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Frédéric Plantevin, MD
Phone
33 1 42 11 44 37
Email
plantevin@igr.fr

12. IPD Sharing Statement

Learn more about this trial

Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery

We'll reach out to this number within 24 hrs